Forward Pharmaceuticals Co

Company snapshot

Forward Pharmaceuticals Co is a pharma organization headquartered in CN. Primary therapeutic focus areas include Metastatic Breast Cancer. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 2 (1).

• 1 active pipeline program(s) linked via ClinicalTrials.gov.
• 1 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Forward Pharmaceuticals Co. Not investment advice.

• What is Forward Pharmaceuticals Co?

  Forward Pharmaceuticals Co is a pharma organization headquartered in CN. Primary therapeutic focus areas include Metastatic Breast Cancer. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov

• Is Forward Pharmaceuticals Co publicly traded?

  Forward Pharmaceuticals Co appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Forward Pharmaceuticals Co develop or market?

  We link 1 drug profile(s) where Forward Pharmaceuticals Co is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/forward-pharmaceuticals-co#company-drugs.

• What are the latest developments for Forward Pharmaceuticals Co?

  In the last 12 months our linked public records show 1 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Forward Pharmaceuticals Co focus on?

  Forward Pharmaceuticals Co focuses on Metastatic Breast Cancer based on our analysis of their pipeline programs and drug development activities.